[Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia]

Jin-rong Liu1, Yun Peng, Hai-ming Yang

  • 1Respiratory and Infectious Diseases Center, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing 100045, China.

Insights

Predictive factors for refractory Mycoplasma pneumoniae pneumonia (RMPP) in children include prolonged fever, elevated CRP, and extensive lung consolidation. Early identification of these markers aids in timely treatment of RMPP.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • Mycoplasma pneumoniae pneumonia (MPP) is common in children.
  • Refractory MPP (RMPP) presents a clinical challenge due to persistent symptoms and potential complications.
  • Early recognition of RMPP is crucial for effective management.

Purpose of the Study:

  • To identify clinical characteristics and predictive factors of RMPP in children.
  • To develop criteria for earlier diagnosis and treatment of RMPP.

Main Methods:

  • Retrospective analysis of 213 children with MPP (72 RMPP, 141 mild MPP).
  • Inclusion of febrile duration, inflammatory markers (WBC, CRP), and radiological findings.
  • Multivariate logistic regression to identify independent risk factors for RMPP.
  • Prospective validation of predictive criteria in 100 additional patients.

Main Results:

  • RMPP patients exhibited longer febrile duration (>10 days) and higher CRP levels (>40 mg/L).
  • Radiological findings in RMPP included large lobar consolidation (>2/3 lobe) with high density (CT value 40-50 HU), often with pleural effusion.
  • Independent predictors for RMPP were prolonged fever, elevated CRP, and extensive consolidation (ORs ranging from 1.586 to 4.344).
  • Diagnostic criteria achieved high sensitivity (0.96) and specificity (0.94) for RMPP.

Conclusions:

  • Prolonged fever (>10 days), elevated CRP (>40 mg/L), and extensive, dense lobar consolidation are key predictors of RMPP.
  • These factors can aid in the early identification and management of RMPP in pediatric patients.
  • The established criteria demonstrate high accuracy in diagnosing RMPP.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: